Open Access

Erratum to: PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer

  • Ji-Youn Han1, 3Email author,
  • Jae-Jin Choi2,
  • Jin Young Kim1,
  • You Lim Han1 and
  • Geon Kook Lee1
BMC Cancer201616:803

https://doi.org/10.1186/s12885-016-2760-9

Received: 5 September 2016

Accepted: 5 September 2016

Published: 17 October 2016

The original article was published in BMC Cancer 2016 16:627

Erratum

Unfortunately, the original version of this article [1] contained an error. Within Fig. 1, Fig. 1c and d were missing. The correct version of Fig. 1 can be found below and has been updated in the original article.
Fig. 1

Schematic representation of EGFR and KRAS mutation detection using PANAMutyperTM: EGFR (a) and KRAS (b). Sensitivity of the EGFR L858R and E19del (c) and KRAS G12V and G12R (d) mutants according to their cellularity by diluting to 100, 10, 1, 0.1, 0.01, 0 % with respect to the wild cell line DNA and mutant cell line DNA. The data presented here are representative obtained from sensitivity test conducted more than 50 times. MT, mutant type

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Lung Cancer Branch, Research Institute, National Cancer Center
(2)
PANAGENE Inc.
(3)
Center for Lung Cancer, Hospital, National Cancer Center

Reference

  1. Han JY, et al. PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer. BMC Cancer. 2016;16:627. doi:https://doi.org/10.1186/s12885-016-2678-2.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement